Professor
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center
Dr. Gershenwald is a surgical oncologist-investigator in the melanoma field. In addition to his melanoma clinical practice for which he received Press Ganey CGCAHPS top 1% Provider Nationally for Exceptional Care in 2023, and leadership roles in the MD Anderson Melanoma and Skin Center, the Melanoma Moon Shot, a Department of Defense - Congressionally Directed Medical Research Program Team Science Award, and an NIH-funded SPORE in Melanoma, he has an active research program that is focused on integrating clinical, pathological, molecular and immune factors to improve melanoma staging and to develop, validate, and implement clinical tools to improve clinical decision-making for patients with melanoma. Dr. Gershenwald earned his medical degree with honors in research at Cornell University Medical College in New York, completed residency training in general surgery at New York Hospital-Cornell Medical Center, and his fellowship in surgical oncology at The University of Texas MD Anderson Cancer Center. He is board certified by the American Board of Surgery, a Fellow of the American Association for the Advancement of Science, an Honorary Fellow of the Royal Australasian College of Surgeons (2022), and has been recognized by both MD Anderson and the Society of Melanoma Research for melanoma prevention initiatives. He served as Chair of the American Joint Committee on Cancer (AJCC) melanoma expert panel, and currently serves as Vice Chair of the AJCC, Chair of the AJCC Executive Committee, and Co-chair of the National Council for Skin Cancer Prevention (NCSCP).